Haemonetics Corporation (HAE) Return on Investment ROI from the second quarter of 2026 to second quarter of 2026 and for the year 2026, average high and low, overall ranking from Sep 26 2026 to Sep 27 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Haemonetics Corporation  (NYSE: HAE)


Haemonetics's ROI from its second quarter of 2026 to the second quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Haemonetics's ROI in the second quarter of 2026?
Haemonetics Corporation achieved a return on average invested assets (ROI) of 4.97 % in its second quarter of 2026, this is above HAE's average return on investment of 4.39%.
Haemonetics Corporations investments during the 12 months ending in the second quarter of 2026 are valued at $2 billion

ROI has improved compared to 4.8% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 147 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1502 to 1507.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 26 2026)
II. Quarter		 (Jun 27 2026)
I. Quarter		 (Mar 28 2026)
IV. Quarter		 (Dec 27 2025)
III. Quarter		 (Sep 27 2025)
II. Quarter
Y / Y Investment Change TTM 5.94 % -2.43 % -9.59 % -6.07 % -0.28 %
Y / Y Net Income Change TTM -38.22 % -41.05 % -24.75 % 145.97 % 397.15 %
Investment (TTM) in Millions 2,110 2,102 2,016 2,138 1,770
Return On Investment (TTM) 4.97 % 4.8 % 5.04 % 9.05 % 8.52 %
HAE's Overall Ranking # 1507 # 1502 # 154 # 804 #
Seq. Investment Change TTM 4.24 % 3.87 % -0.38 % -1.78 % -4 %
Seq. Net Income Change TTM 7.91 % -1.05 % -44.53 % 4.31 % 2.97 %
Net Income (TTM) in Millions 104 96 97 175 168

HAE Company Profile >> Back to HAE Roi Comparisons >> See Annual HAE Return On Investment



Return On Investment HAE's Ranking
Within: No.
Industry # 46
Sector # 148
Overall # 1507

Return On Investment Statistics
High Average Low
11.62 %
4.39 %
-5.5 %
(Jul 02 2011)   (Jul 02 2016)







Financial Statements
Haemonetics's II. Quarter Investments $ 2,110 Millions HAE's Balance sheet
Haemonetics's II. Quarter Income $ 46 Millions Quarterly HAE's Income Statement
HAE's Income by Division See HAE's Income by Division


HAE Annual Return On Investment (Mar 28 2026)
2026		 (Mar 29 2025)
2025		 (Mar 30 2024)
2024		 (Apr 01 2023)
2023		 (Apr 02 2022)
2022
Total Investments in Millions 2,016 1,742 1,758 1,572 1,389
Y / Y Investment Growth 15.72 % -0.88 % 11.79 % 13.2 % -8.79 %
Net Income in Millions 97 168 118 115 43
Y / Y Net Income Growth -41.97 % 42.64 % 1.87 % 166.05 % -45.42 %
Annual Return On Investment 4.83 % 9.63 % 6.69 % 7.34 % 3.12 %


Annual Roi Comment
In the fiscal year 2026 ROI decreased relative to the previous year to 4.83 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HAE's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HAE's Competitors
Subscribers only: Roi for Haemonetics's Suppliers
Subscribers only: Return On Investment for HAE's Customers

Other Ratios
HAE's Roa HAE's Inventory Turnover Ratio HAE's Growth Rates HAE's Dividend Statistics
HAE's Profitability Ratios HAE's Asset Turnover Ratio HAE's Dividend Growth
HAE's Roe HAE's Valuation Ratios HAE's Financial Strength Ratios HAE's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 26 2026, within Healthcare Sector ROI
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Alpha Pro Tech Ltd   13.18 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %
Stryker Corp  8.63 %
Pediatrix Medical Group Inc   8.37 %
Penumbra Inc  8.28 %
Medinotec Inc   8.12 %
Pacific Health Care Organization Inc  8.09 %
Quest Diagnostics Inc  8.01 %
Ge Healthcare Technologies Inc   7.60 %
Incyte Corporation  6.81 %

Date modified: 2026-11-08T19:25:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.